Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on January 31, 2022, the compensation committee of the Company's Board of Directors granted non-qualified stock option awards to purchase an aggregate of 525,600 shares of its common stock to four new employees under the ImmunoGen, Inc. Inducement Equity Incentive Plan (the "Inducement Plan"). The stock options were granted as an inducement material to the new employees' becoming employees of ImmunoGen in accordance with Nasdaq Listing Rule 5635(c)(4).

The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of ImmunoGen (or following a bona fide period of non-employment), as an inducement material to such individual's entering into employment with ImmunoGen, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.

The options have an exercise price of $5.65 per share, which is equal to the closing price of ImmunoGen's common stock on the Nasdaq Global Select Market on January 31, 2022. Each option will vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant, subject to such employee's continued employment with ImmunoGen on such vesting dates. Each option is subject to the terms and conditions of the Inducement Plan and the terms and conditions of a stock option agreement covering the grant.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOWtm.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.


These press releases may also interest you

at 16:59
Catholic Charities USA (CCUSA), the official domestic relief agency of the U.S. Catholic Church, launched a dedicated disaster donation page with 100 percent of the monies raised going to support people impacted by Hurricane Ian and served by their...

at 10:35
Faces & Voices of Recovery is pleased to announce Dr. Rahul Gupta as a guest speaker at the annual Recovery Leadership Summit, held this year in St. Paul, MN from October 2-5. Rahul Gupta, MD, MPH, MBA, FACP, is the first medical doctor to serve as...

at 10:34
October is National Liver Awareness Month and the American Liver Foundation is encouraging everyone to find out if they are at risk for fatty liver disease through its public awareness campaign, Think Liver Think Lifetm.  Fatty liver disease affects...

at 10:12
Today, the Minister of Seniors, Kamal Khera and the Minister of Health, Jean-Yves Duclos, issued the following statement: "Happy National Seniors Day! Every year, on October 1st, we celebrate seniors in Canada and express our gratitude for all of...

at 10:01
The Janssen Pharmaceutical Companies of Johnson & Johnson...

at 09:00
The Prime Minister, Justin Trudeau, today issued the following statement on National Seniors Day: "Seniors worked hard all their lives to build a better Canada for today and for future generations. On National Seniors Day, I join all Canadians in...



News published on 1 february 2022 at 16:35 and distributed by: